V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215983 | 20082011 | null | null | null | 2020-07-25 | 2020-08-07 | null | null | null | CAPECITABINE + IRINOTECAN | 100616183 |
| 20215986 | 20082013 | 1.61 | 71.8 | Neo-adjuvant (N) | null | 2019-05-30 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101139938 |
| 20215987 | 20082014 | null | null | null | 2018-11-29 | 2018-12-18 | ECF | 02 | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100166518 |
| 20215990 | 20082017 | null | null | null | null | 2019-08-10 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101763977 |
| 20215991 | 20082018 | null | null | null | 2019-08-15 | 2019-09-02 | ECarboX | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101443682 |
| 20215993 | 20082019 | 1.76 | 76 | Palliative (P) | 2018-10-01 | 2018-10-01 | CAPECITABINE + IRINOTECAN | 02 | N | CAPECITABINE + IRINOTECAN | 101452238 |
| 20215994 | 20082020 | 1.66 | null | Palliative (P) | 2019-04-06 | 2019-04-14 | CETUXIMAB + IRINOTECAN + MDG | N | N | CETUXIMAB + IRINOTECAN + MDG | 101576556 |
| 20215995 | 20082021 | null | null | null | 2019-09-04 | 2019-09-04 | Cisplatin + Etoposide po&iv 3 day | 02 | null | CISPLATIN + ETOPOSIDE | 100946602 |
| 20215996 | 20082022 | 1.75 | 58.3 | Palliative (P) | null | 2018-08-28 | null | null | N | CAPECITABINE + IRINOTECAN | 101737527 |
| 20215997 | 20082023 | 1.65 | 134 | Neo-adjuvant (N) | null | 2019-09-01 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101042616 |
| 20215998 | 20082024 | null | null | null | 2018-09-11 | 2018-09-11 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101678458 |
| 20216000 | 20082025 | null | null | null | 2018-11-15 | 2018-12-11 | LENVATINIB | 02 | null | LENVATINIB | 101764939 |
| 20216001 | 20082026 | 1.65 | 84 | Neo-adjuvant (N) | 2018-05-25 | 2018-06-19 | null | null | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100690738 |
| 20216004 | 20082027 | 1.75 | 86.2 | Neo-adjuvant (N) | null | 2021-04-26 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100298733 |
| 20216005 | 20082028 | null | null | null | 2016-12-01 | 2016-12-01 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100256686 |
| 20216007 | 20082030 | 1.58 | 100.9 | Neo-adjuvant (N) | 2016-01-31 | 2016-03-27 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 100862204 |
| 20216008 | 20082031 | null | null | null | 2017-06-08 | 2017-06-08 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 100058043 |
| 20216009 | 20082032 | null | null | null | 2015-08-17 | 2015-08-24 | CAPECITABINE + IRINOTECAN | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101693591 |
| 20216011 | 20082034 | 1.46 | 56 | Palliative (P) | 2017-03-01 | 2017-03-16 | null | null | N | HCX | 100421998 |
| 20216013 | 20082035 | 1.63 | 77.8 | Palliative (P) | 2019-12-15 | 2019-12-26 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101273918 |
| 20216014 | 20082036 | 1.66 | 89.5 | null | 2019-04-25 | 2019-05-09 | CETUXIMAB + IRINOTECAN + MDG | N | null | CETUXIMAB + IRINOTECAN + MDG | 101344523 |
| 20216015 | 20082037 | 1.64 | 81 | Palliative (P) | null | 2016-04-09 | null | null | N | HCX | 100791060 |
| 20216018 | 20082039 | 1.64 | 84 | Palliative (P) | null | 2018-01-11 | null | null | N | HCX | 100464033 |
| 20216019 | 20082040 | 1.73 | 73 | Neo-adjuvant (N) | 2020-03-19 | 2020-03-25 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101409360 |
| 20216021 | 20082041 | 1.69 | 61.2 | Palliative (P) | null | 2020-02-29 | null | null | N | LENVATINIB | 101029238 |
| 20216022 | 20082042 | 1.8 | 74.9 | Palliative (P) | 2016-03-23 | 2016-03-26 | LENVATINIB | 02 | N | LENVATINIB | 100333201 |
| 20216024 | 20082043 | 1.77 | 56 | null | 2016-09-08 | 2016-09-22 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + MITOMYCIN + RT | 101241366 |
| 20216031 | 20082046 | 1.68 | 93 | Palliative (P) | 2018-09-11 | 2018-09-28 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100622443 |
| 20216036 | 20082050 | null | null | null | 2018-10-16 | 2018-10-24 | null | null | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101070870 |
| 20216037 | 20082051 | null | null | null | 2020-02-11 | 2020-02-11 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101352165 |
| 20216040 | 20082053 | 1.53 | 94 | Palliative (P) | 2019-03-08 | 2019-03-12 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | CETUXIMAB + IRINOTECAN + MDG | 101311692 |
| 20216041 | 20082054 | null | null | null | null | 2019-03-11 | null | null | null | CAPECITABINE + MITOMYCIN + RT | 100510898 |
| 20216042 | 20082055 | 1.82 | 53.4 | Palliative (P) | null | 2018-06-21 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101399212 |
| 20216043 | 20082056 | null | null | null | null | 2016-05-10 | null | null | null | HCX | 100160513 |
| 20216044 | 20082057 | 1.71 | 56.2 | Palliative (P) | 2016-10-09 | 2016-10-09 | LENVATINIB | 02 | N | LENVATINIB | 101163394 |
| 20216049 | 20082060 | 1.6 | 83 | Neo-adjuvant (N) | null | 2020-08-07 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101184128 |
| 20216051 | 20082062 | 1.48 | 65 | 03 | 2018-06-29 | 2018-06-29 | null | null | N | CAPECITABINE + IRINOTECAN | 101195042 |
| 20216052 | 20082063 | null | null | null | null | 2019-08-24 | null | null | null | CISPLATIN + ETOPOSIDE | 101521725 |
| 20216054 | 20082065 | null | null | null | null | 2018-02-15 | null | null | null | HCX | 100482630 |
| 20216055 | 20082066 | 1.61 | 92.8 | null | null | 2019-10-11 | null | null | null | CISPLATIN + ETOPOSIDE | 100541948 |
| 20216056 | 20082067 | null | null | null | null | 2018-09-14 | null | null | null | HCX | 101520279 |
| 20216058 | 20082069 | null | null | null | 2018-03-30 | 2018-04-29 | CAPECITABINE + MITOMYCIN + RT | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101852044 |
| 20216059 | 20082070 | 1.68 | 62.1 | Palliative (P) | 2021-10-02 | 2021-10-02 | ECarboX | N | N | CETUXIMAB + IRINOTECAN + MDG | 100967324 |
| 20216061 | 20082071 | null | null | null | 2019-05-22 | 2019-05-26 | ECarboX | 2 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101321817 |
| 20216062 | 20082072 | 0 | 59.4 | Palliative (P) | 2018-10-29 | 2018-11-08 | ECarboX | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100302421 |
| 20216063 | 20082073 | 1.8 | null | Palliative (P) | 2017-11-10 | 2017-11-22 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100521537 |
| 20216064 | 20082074 | 1.81 | 82.5 | Palliative (P) | null | 2019-08-13 | null | null | N | HCX | 101333530 |
| 20216065 | 20082075 | null | 110.1 | Curative (C) | 2018-04-13 | 2018-04-21 | null | null | null | CISPLATIN + ETOPOSIDE | 101005031 |
| 20216066 | 20082076 | 1.55 | 63.9 | Neo-adjuvant (N) | null | 2017-08-04 | null | null | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100152039 |
| 20216067 | 20082077 | 1.74 | 76 | Palliative (P) | null | 2018-05-26 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100741522 |